Drawing for EMHANCE

USPTO serial 99641435

EMHANCE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SCHAEFER, REBECCA ANN
Law office
TMO LAW OFFICE 122

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with EMHANCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dennis H. Cavanaugh

Dennis H. Cavanaugh D H CAVANAUGH ASSOCIATES260 MADISON AVENUE, FL 16FL 16New York, NY 10016

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for market data analysis; Downloadable software using artificial intelligence for simulating natural conversation; Downloadable software using artificial intelligence (AI) for summarizing texts; Downloadable software using artificial intelligence (AI) for simulating natural conversation; Downloadable computer software for generating images from text using artificial intelligence; Downloadable software using artificial intelligence for writing content based on a theme; Downloadable computer software for collecting, analyzing and organizing data in the field of deep learning; Downloadable text-to-image generator software using artificial intelligence (AI); Downloadable software using artificial intelligence (AI) for summarizing audiovisual data; all of the above listed software not for use in the fields of medicine, medical use, medical patient treatment, diagnosis and therapy, physical therapy, rehabilitative and pain management purposes, surgical procedures and neurology, nerve stimulation, body rehabilitation apparatus for medical purposes, medical devices for use in treating or diagnosing diseases and disorders of the nervous system, medical instruments for measuring and displaying the electromagnetic signals produced by internal bodily organs and tissues, or medical imaging apparatusACTIVE—
035Market research services; Business services, namely, consumer research and consulting related thereto; Marketing research services in the nature of tracking consumer behavior and analyzing consumer trends; Business data analysis services in the field of consumer preferences; Data processing servicesACTIVE—
042Providing online non-downloadable software using artificial intelligence (AI) for machine learning; Providing online non-downloadable text-to-image generator software using artificial intelligence (AI); Scientific and technological services, namely, scientific research, testing, analysis, data processing, and AI analysis in the field of consumer preferences and marketing; Research and development of technology in the field of artificial intelligence; Research and development in the field of artificial intelligence; Software as a service (SAAS) services featuring software for data analysis; Technology specification, namely, analyzing technology requirements and developing recommendations for the computer software and systems and other technology needed to meet those requirements, in the field of consumer preferences and market research; Design and development of computer software; all of the above listed software not for use in the fields of medicine, medical use, medical patient treatment, diagnosis and therapy, physical therapy, rehabilitative and pain management purposes, surgical procedures and neurology, nerve stimulation, body rehabilitation apparatus for medical purposes, medical devices for use in treating or diagnosing diseases and disorders of the nervous system, medical instruments for measuring and displaying the electromagnetic signals produced by internal bodily organs and tissues, or medical imaging apparatusACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 5, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 7, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2026DOCKASSIGNED TO EXAMINER—
Jun 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 9, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 9, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance